Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02665858
Other study ID # 0035-15-HYMC
Secondary ID
Status Not yet recruiting
Phase N/A
First received January 24, 2016
Last updated January 24, 2016
Start date February 2016
Est. completion date February 2017

Study information

Verified date January 2016
Source Hillel Yaffe Medical Center
Contact Yuval Cohen, MD, PhD
Phone 972-586904951
Email dr.yuvalcohen@gmail.com
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

Longitudinal clinical observation of optic nerve head, using slit lamp fundoscopy, guides therapy in pediatric idiopathic intracranial hypertension (IIH) patients; however, it remains a limited method of producing quantitative data in evaluating in patients with IIH.

In this study we intend to compare, by using spectral domain optical coherence tomography (OCT), the mean retinal nerve fiber layer thickness and total retinal thickness (RNFLT/TRT) of the optic nerve of newly diagnosed IIH children to a control group. This will provide a quantitative measure for follow-up and treatment of this patient group.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date February 2017
Est. primary completion date February 2017
Accepts healthy volunteers No
Gender Both
Age group 5 Years to 18 Years
Eligibility Inclusion Criteria:

- Children with suspected IIH

Exclusion Criteria:

- Retinal disease

- High refractive error

- Unable to undergo OCT imaging

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
OCT Imaging


Locations

Country Name City State
Israel Hillel Yaffe Medical Center Hadera

Sponsors (1)

Lead Sponsor Collaborator
Hillel Yaffe Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of RNFLT/TRT Thickness One year No